A W M Cheng1, M Bolognesi2, V B Kraus3. 1. Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. 2. Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. 3. Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: vbk@duke.edu.
Abstract
OBJECTIVE: Selenium neutralizes interleukin-1β (IL-1β) induced inflammatory responses in chondrocytes. We investigated potential mechanisms for this through in vitro knock down of three major selenoproteins, Iodothyronine Deiodinase-2 (DIO2), Glutathione Peroxidase-1 (GPX1), and Thioredoxin Reductase-1 (TR1) in primary human chondrocytes. METHODS: Primary human chondrocytes were transfected with scrambled small interfering ribonucleic acid (siRNA) or siRNA specific for DIO2, GPX1 and TR1. After 48 h, transfected cells were cultured in serum free media for 48 h, with or without 10 pg/ml IL-1β for the final 24h. The efficiency of siRNAs was confirmed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot analysis. The gene expression, by qRT-PCR, of cyclooxygenase-2 (COX2), IL-1β, and Liver X receptor (LXR) alpha and beta was evaluated to determine the impact of selenoprotein knockdown on inflammatory responses in chondrocytes. RESULTS: The messenger RNA (mRNA) expression of DIO2, GPX1, and TR1 was significantly decreased by the specific siRNAs (reduced 56%, P=0.0004; 96%, P<0.0001; and 66%, P<0.0001, respectively). Suppression of DIO2, but not GPX1 or TR1, significantly increased (~2-fold) both basal (P=0.0005) and IL-1β induced (P<0.0001) COX2 gene expression. Similarly, suppression of DIO2 significantly increased (∼9-fold) IL-1β induced IL-1β gene expression (P=0.0056) and resulted in a 32% (P=0.0044) decrease in LXRα gene expression but no effect on LXRβ. CONCLUSIONS: Suppression of the selenoprotein DIO2 resulted in strong pro-inflammatory effects with increased expression of inflammatory mediators, IL-1β and COX2, and decreased expression of LXRα suggesting that this may be the upstream target through which the anti-inflammatory effects of DIO2 are mediated.
OBJECTIVE:Selenium neutralizes interleukin-1β (IL-1β) induced inflammatory responses in chondrocytes. We investigated potential mechanisms for this through in vitro knock down of three major selenoproteins, Iodothyronine Deiodinase-2 (DIO2), Glutathione Peroxidase-1 (GPX1), and Thioredoxin Reductase-1 (TR1) in primary human chondrocytes. METHODS: Primary human chondrocytes were transfected with scrambled small interfering ribonucleic acid (siRNA) or siRNA specific for DIO2, GPX1 and TR1. After 48 h, transfected cells were cultured in serum free media for 48 h, with or without 10 pg/ml IL-1β for the final 24h. The efficiency of siRNAs was confirmed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot analysis. The gene expression, by qRT-PCR, of cyclooxygenase-2 (COX2), IL-1β, and Liver X receptor (LXR) alpha and beta was evaluated to determine the impact of selenoprotein knockdown on inflammatory responses in chondrocytes. RESULTS: The messenger RNA (mRNA) expression of DIO2, GPX1, and TR1 was significantly decreased by the specific siRNAs (reduced 56%, P=0.0004; 96%, P<0.0001; and 66%, P<0.0001, respectively). Suppression of DIO2, but not GPX1 or TR1, significantly increased (~2-fold) both basal (P=0.0005) and IL-1β induced (P<0.0001) COX2 gene expression. Similarly, suppression of DIO2 significantly increased (∼9-fold) IL-1β induced IL-1β gene expression (P=0.0056) and resulted in a 32% (P=0.0044) decrease in LXRα gene expression but no effect on LXRβ. CONCLUSIONS: Suppression of the selenoprotein DIO2 resulted in strong pro-inflammatory effects with increased expression of inflammatory mediators, IL-1β and COX2, and decreased expression of LXRα suggesting that this may be the upstream target through which the anti-inflammatory effects of DIO2 are mediated.
Authors: Anikó Zeöld; Márton Doleschall; Michael C Haffner; Luciane P Capelo; Judit Menyhért; Zsolt Liposits; Wagner S da Silva; Antonio C Bianco; Imre Kacskovics; Csaba Fekete; Balázs Gereben Journal: Endocrinology Date: 2006-05-25 Impact factor: 4.736
Authors: K Sandeep Prabhu; Faith Zamamiri-Davis; Jennifer B Stewart; Jerry T Thompson; Lorraine M Sordillo; C Channa Reddy Journal: Biochem J Date: 2002-08-15 Impact factor: 3.857
Authors: Ning Li; Moisés A Rivéra-Bermúdez; Mei Zhang; Julio Tejada; Sonya S Glasson; Lisa A Collins-Racie; Edward R Lavallie; Yihe Wang; Ken C N Chang; Sunil Nagpal; Elisabeth A Morris; Carl R Flannery; Zhiyong Yang Journal: Proc Natl Acad Sci U S A Date: 2010-02-03 Impact factor: 11.205
Authors: Thomas Aigner; Katrin Fundel; Joachim Saas; Pia M Gebhard; Jochen Haag; Tilo Weiss; Alexander Zien; Franz Obermayr; Ralf Zimmer; Eckart Bartnik Journal: Arthritis Rheum Date: 2006-11
Authors: Kosei Ijiri; Luiz F Zerbini; Haibing Peng; Hasan H Otu; Kaneyuki Tsuchimochi; Miguel Otero; Cecilia Dragomir; Nicole Walsh; Benjamin E Bierbaum; David Mattingly; Geoff van Flandern; Setsuro Komiya; Thomas Aigner; Towia A Libermann; Mary B Goldring Journal: Arthritis Rheum Date: 2008-07
Authors: Walter H Watson; Jacqueline M Heilman; Laura L Hughes; Jeanine C Spielberger Journal: Biochem Biophys Res Commun Date: 2008-02-11 Impact factor: 3.575
Authors: L A Collins-Racie; Z Yang; M Arai; N Li; M K Majumdar; S Nagpal; W M Mounts; A J Dorner; E Morris; E R LaVallie Journal: Osteoarthritis Cartilage Date: 2009-01-19 Impact factor: 6.576
Authors: Gábor Wittmann; John W Harney; Praful S Singru; Shira S Nouriel; P Reed Larsen; Ronald M Lechan Journal: Endocrinology Date: 2014-03-06 Impact factor: 4.736
Authors: Gábor Wittmann; Judit Szabon; Petra Mohácsik; Shira S Nouriel; Balázs Gereben; Csaba Fekete; Ronald M Lechan Journal: Endocrinology Date: 2015-01-16 Impact factor: 4.736
Authors: Aniruddha Sengupta; Ulrike F Lichti; Bradley A Carlson; Christophe Cataisson; Andrew O Ryscavage; Carol Mikulec; Marcus Conrad; Susan M Fischer; Dolph L Hatfield; Stuart H Yuspa Journal: J Invest Dermatol Date: 2013-01-30 Impact factor: 8.551